Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022

BUY
$76.85 - $89.45 $9,222 - $10,734
120 Added 1.73%
7,071 $548,000
Q4 2021

Jan 21, 2022

BUY
$74.57 - $87.19 $39,522 - $46,210
530 Added 8.25%
6,951 $597,000
Q3 2020

Oct 14, 2020

SELL
$78.33 - $90.73 $6,188 - $7,167
-79 Reduced 1.22%
6,421 $516,000
Q2 2020

Jul 23, 2020

BUY
$78.66 - $94.14 $54,983 - $65,803
699 Added 12.05%
6,500 $560,000
Q1 2020

Apr 21, 2020

SELL
$71.57 - $93.3 $10,019 - $13,062
-140 Reduced 2.36%
5,801 $471,000
Q4 2019

Jan 10, 2020

BUY
$76.7 - $88.45 $6,059 - $6,987
79 Added 1.35%
5,941 $497,000
Q3 2019

Oct 21, 2019

BUY
$81.4 - $89.78 $97,680 - $107,736
1,200 Added 25.74%
5,862 $513,000
Q3 2018

Oct 23, 2018

BUY
$70.71 - $77.75 $5,091 - $5,598
72 Added 1.57%
4,662 $359,000
Q3 2017

Oct 13, 2017

BUY
$59.5 - $64.61 $273,105 - $296,559
4,590
4,590 $288,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Boston Trust Walden Corp Portfolio

Follow Boston Trust Walden Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.